⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 18, 2024

Table S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in Caenorhabditis elegans

Szymon Gorgoń Ola Billing Anna U. Eriksson Oskar Hemmingsson

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Supplementary table 1. All Compounds and Exclusions

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gorgoń et al. (2024) studied this question.

synapsesocial.com/papers/68e581f0b6db64358751fb3f https://doi.org/10.1158/2767-9764.27052897.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024
2Figure 6 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024
3Figure S2 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024
4Figure S4 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024
5Figure S3 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024

More related papers

Figure 3 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024
Figure S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024
Data from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>2024